Three GLP-1 drugs are best at helping obese and overweight people drop weight, including one that hasn’t yet been ap ...

Novo Nordisk faces scrutiny over UK pharmacy sponsorships tied to weight-loss drugs, with critics citing conflicts of interest and regulatory breaches.

A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

Claiming Science magazine's breakthrough of the year in 2023 , these drugs are an absolute revelation: they give you long-lasting weight loss as long as you continue taking them .

Weight-loss drugs such as Ozempic, Wegovy, Saxenda and Mounjaro are known as 'GLP-1 agonists'. They work by mimicking glucagon-like peptide 1, the naturally occurring hormone that helps us feel ...

This is the beginning of a revolution, and how you engage and how you attack it is going to really set the stage for your ...

In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies ...

Novo Nordisk petitions the FDA to exclude liraglutide from the 503B Bulks List, citing safety risks, lack of clinical need, ...

Novo Nordisk (NOVO) is petitioning the FDA to exclude its diabetes drug liraglutide, also known as Victoza, from a list of ...

For Floridians, 2024 was a year of weight loss and emerging revelations about anti-obesity medications.